2seventy bio, Inc. revenue for the last year amounted to 100.39 M USD, the most of which — 100.39 M USD — came from its highest performing source at the moment, Treatments for Cancer, the year earlier bringing 91.50 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought 2seventy bio, Inc. 100.39 M USD, and the year before that — 91.50 M USD.